Anteris Technologies Global (NASDAQ:AVR) Posts Quarterly Earnings Results, Misses Expectations By $0.09 EPS

Anteris Technologies Global (NASDAQ:AVR) announced its earnings results on Tuesday. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.09), FiscalAI reports. Anteris Technologies Global had a negative net margin of 4,619.27% and a negative return on equity of 110.36%. The firm had revenue of $1.01 million during the quarter, compared to analysts’ expectations of $1.50 million. During the same quarter in the prior year, the company earned ($0.58) EPS.

Anteris Technologies Global Stock Down 3.3%

Shares of NASDAQ:AVR opened at $8.87 on Thursday. The firm has a market capitalization of $863.42 million, a PE ratio of -4.55 and a beta of 1.78. The company has a 50-day moving average price of $9.15 and a two-hundred day moving average price of $7.35. Anteris Technologies Global has a twelve month low of $3.30 and a twelve month high of $11.06.

Analyst Ratings Changes

A number of brokerages have recently weighed in on AVR. Wall Street Zen upgraded Anteris Technologies Global from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Friday, May 29th. Finally, Barclays boosted their price objective on Anteris Technologies Global from $17.00 to $18.00 and gave the stock an “overweight” rating in a research report on Friday, May 15th. Four research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $16.00.

Insider Buying and Selling

In related news, major shareholder L1 Capital Pty Ltd sold 558,633 shares of Anteris Technologies Global stock in a transaction that occurred on Thursday, July 30th. The shares were sold at an average price of $8.20, for a total value of $4,580,790.60. Following the completion of the transaction, the insider directly owned 6,633,314 shares in the company, valued at approximately $54,393,174.80. The trade was a 7.77% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last ninety days, insiders have sold 3,000,659 shares of company stock valued at $25,174,702. 4.50% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Anteris Technologies Global

Several hedge funds have recently made changes to their positions in the stock. L1 Capital Pty Ltd lifted its holdings in Anteris Technologies Global by 143.2% during the 3rd quarter. L1 Capital Pty Ltd now owns 6,838,136 shares of the company’s stock worth $30,772,000 after purchasing an additional 4,026,136 shares in the last quarter. Nantahala Capital Management LLC grew its holdings in Anteris Technologies Global by 31.9% during the 4th quarter. Nantahala Capital Management LLC now owns 2,530,910 shares of the company’s stock valued at $12,629,000 after buying an additional 612,244 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in Anteris Technologies Global by 32.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,417,627 shares of the company’s stock valued at $6,379,000 after buying an additional 349,299 shares in the last quarter. ADAR1 Capital Management LLC increased its position in shares of Anteris Technologies Global by 526.9% during the fourth quarter. ADAR1 Capital Management LLC now owns 1,238,777 shares of the company’s stock valued at $6,181,000 after buying an additional 1,041,162 shares during the period. Finally, Geode Capital Management LLC increased its position in shares of Anteris Technologies Global by 6.3% during the fourth quarter. Geode Capital Management LLC now owns 796,069 shares of the company’s stock valued at $3,973,000 after buying an additional 47,119 shares during the period.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.